Verde Clean Fuels, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Verde Clean Fuels, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.96M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($3.33M) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($2.74M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.72M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($474.6K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($4.7K) | Mar 30, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($16.45M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($11.66M) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($10.55M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.72M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($456.8K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($4.7K) | Mar 30, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $591.0K | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $451.0K | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $329.2K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $316.7K | Mar 28, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.89M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($8.88M) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($9.11M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($3.28M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($528.3K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($2.2K) | Mar 30, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.69M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.55M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $58.6K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.4K | Mar 28, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.25M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $23.57M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $31.93M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $6.36M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $174.96M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $198.6K | Mar 30, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.11M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.89M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.10M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $5.25M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $6.28M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $178.3K | Mar 30, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | ($10.87M) | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | ($5.55M) | Mar 31, 2023 |
| FY2022 | Dec 31, 2020 | $20.3K | Mar 31, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($34.22M) | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | ($27.26M) | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | ($23.92M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($11.67M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($5.55M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($4.7K) | Mar 30, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.22M | Mar 27, 2026 |
| FY2025 | Dec 31, 2024 | $19.04M | Mar 27, 2026 |
| FY2024 | Dec 31, 2023 | $28.78M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $463.5K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $505.5K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $11.1K | Mar 30, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 28, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Mar 30, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Nov 7, 2022 | 21.75M | Mar 31, 2023 |